Last reviewed · How we verify
Telitacicept Freeze-dried powder Injection 80mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Telitacicept Freeze-dried powder Injection 80mg (Telitacicept Freeze-dried powder Injection 80mg) — RemeGen Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Telitacicept Freeze-dried powder Injection 80mg TARGET | Telitacicept Freeze-dried powder Injection 80mg | RemeGen Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Telitacicept Freeze-dried powder Injection 80mg CI watch — RSS
- Telitacicept Freeze-dried powder Injection 80mg CI watch — Atom
- Telitacicept Freeze-dried powder Injection 80mg CI watch — JSON
- Telitacicept Freeze-dried powder Injection 80mg alone — RSS
Cite this brief
Drug Landscape (2026). Telitacicept Freeze-dried powder Injection 80mg — Competitive Intelligence Brief. https://druglandscape.com/ci/telitacicept-freeze-dried-powder-injection-80mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab